Atlas Trials

Phase 1 Study of Fusilev® to Prevent or Reduce Mucositis in Patients With Non-Small Cell Lung Cancer Receiving Folotyn®

Clinical trial NCT01820091 · WITHDRAWN

Trial details

NCT number
NCT01820091
Sponsor
Acrotech Biopharma Inc.
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Non-Small Cell Lung Cancer
Start date
2013-04-01
Primary completion
2015-04-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.